Publications

■Allergic disease（adult）

2023.4～2024.3 

1）Development of a new HISCL automated CXCL9 immunoassay
Hasegawa T, Yoshida M, Watanabe S, Kondo T, Asada H, Nakagawa A, Tomii K, Kameda M, Otsuka M, Kuronuma K, Chiba H, Katayanagi S, Miyazaki Y, Mori A.
Scientific Reports .2023 Apr 1;13(1):5342.

2）Longitudinal changes in the prevalence of adult asthma: An epidemiological survey among Japanese salaried employees and their dependents using healthcare insurance claim from 1999 to 2019
Nagayama K, Fukutomi Y, Nakatani E, Hamada Y, Irie M, Azekawa K, Tomita Y, Watai K, Kamide Y, Sekiya K, Nakamura Y, Okada C, Shimoda T, Nagao M, Fujisawa T, Taniguchi M.
Allergology International. 2023 Apr;72(2):245-251.

3）Prevalence of Allergic Diseases across All Ages in Japan: A Nationwide Cross-Sectional Study Employing Designated Allergic Disease Medical Hospital Network
Ito Y, Kato T, Yoshida K, Takahashi K, Fukutomi Y, Nagao M, Fukuie T, Matsuzaki H, Gotoh M, Tanaka A, Konno S, Tezuka J, Nakamura Y, Adachi Y
Japan Medical Association Journal.2023 Apr 14;6(2):165-174

4）Frailty and muscle weakness in elderly patients with asthma and their association with cumulative lifetime oral corticosteroid exposure
Ryu K, Fukutomi Y, Nakatani E, Iwata M, Nagayama K, Yano K, Nakamura Y, Hamada Y, Watai K, Kamide Y, Sekiya K, Araya J, Kuwano K, Taniguchi M.
Allergology International. 2023 Apr;72(2):252-261.

5）Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan
Suzukawa M, Ohta K, Hashimoto H, Oyamada Y, Miki M, Ogawara M, Inoue Y, Saito AM, Fukutomi Y, Kobayashi N, Taniguchi M; NHOM-Asthma study group.
Annals of Allergy, Asthma and Immunology. 2023 May;130(5):607-616.e3.

6）Omalizumab ameliorates extra-respiratory symptoms in patients with aspirin-exacerbated respiratory disease
Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Tomita Y, Kamide Y, Tsuburai T, Sekiya K, Ishii M, Hasegawa Y, Taniguchi M
Journal of Allergy and Clinical Immunology.2023 Jun;151(6):1667-1672.e2. Epub 2023 Mar 24.

7）Phenotype characterization and biomarker evaluation in moderate to severe type 2-high asthma
Imoto S, Suzukawa M, Fukutomi Y, Kobayashi N, Taniguchi M, Nagase T, Ohta K
Asian Pacific Journal of Allergy and Immunology. 2023 Jun 11

8）Computed tomography findings of paranasal sinuses in patients with eosinophilic granulomatosis with polyangiitis: Comparison with other eosinophilic sinus diseases and clinical relevance of their severity
Iwata M,Fukutomi Y,Hamada Y,Nakamura Y,Watai K, Kamide Y,Ishii T,Taniguchi M,Sekiya K
Allergology International.2023 Jul;72(3):428-436.

9) A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity
Kallen EJJ, Revers A, Fernández-Rivas M, Asero R, Ballmer-Weber B, Barreales L, Belohlavkova S, de Blay F, Clausen M, Dubakiene R, Ebisawa M, Fernández-Perez C, Fritsche P, Fukutomi Y, Gislason D, Hoffmann-Sommergruber K, Jedrzejczak-Czechowicz M, Knulst AC, Kowalski ML, Kralimarkova T, Lidholm J, Metzler C, Mills ENC, Papadopoulos NG, Popov TA, Purohit A, Reig I, Seneviratne SL, Sinaniotis A, Takei M, Versteeg SA, Vassilopoulou AE, Vieths S, Welsing PMJ, Zwinderman AH, Le TM, Van Ree R
Allergy. 2023 Sep;78(9):2497-2509.

10）Analysis of the Factors That Affect the Detection Duration of SARS-CoV-2 in Loop Mediated Isothermal Amplification among COVID-19 Inpatients
Maruyama K，Sekiya K，Yanagida N，Nakayama K，Kushida Y，Yasuda S，Fukumoto D，Hosoya S，Moriya H，Katsumi M
Japanese Journal of Infectious Diseases . 2023 Sep 22;76(5):282-288.

11）Leukotriene antagonists reduce epileptic seizures-related hospitalization in older adult populations with allergic rhinitis or asthma: A population-based cohort study using the Shizuoka Kokuho database: The Shizuoka Study
Imaichi Y, Nakatani E, Fukutomi Y, Kuriyama N, Mori K, Sugawara A
Epilepsia Open. 2023 Oct 25.

12）Validation of asthma discrimination criteria using health insurance claims data in Japan: Additional proposals for more specific criteria. .
Hamada Y, Nakatani E, Nagahama T, Nagai K, Nagayama K, Tomita Y, Kamide Y, Sekiya K, Taniguchi M, Fukutomi Y
Allergol Int. 2023 Oct;72(4):594-596.

13）Serum MMP3 and IL1-RA levels may be useful biomarkers for detecting asthma and chronic obstructive pulmonary disease overlap in patients with asthma
Takada K, Suzukawa M, Tashimo H, Ohshima N, Fukutomi Y, Kobayashi N, Taniguchi M, Ishii M, Akishita M, Ohta K.
World Allergy Organization Journal. 2023 Nov 9;16(11):100840.

14）Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis
Okada N, Yamamoto Y, Oguma T, Tanaka J, Tomomatsu K, Shiraishi Y, Matsuse H, Shimoda T, Kimura H, Watai K, Harada T, Fujita Y, Obase Y, Suzukawa M, Suzuki J, Takayanagi N, Ishiguro T, Masaki K, Fukunaga K, Asano K.
Allergy.2023 NOV.;78(11): 2933-2943.

15）Hypersensitivity to intravenous succinate corticosteroids in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease
Taniguchi M，Sato A，Mita H
Frontiers in Allergy. 2023 Nov 10:4:1145809.

16）Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune
Oguma T, Ishiguro T, Kamei K, Tanaka J, Suzuki J, Hebisawa A, Obase Y, Mukae H, Tanosaki T, Furusho S, Kurokawa K, Watai K, Matsuse H, Harada N, Nakamura A, Shibayama T, Baba R, Fukunaga K, Matsumoto H, Ohba H, Sakamoto S, Suzuki S, Tanaka S, Yamada T, Yamasaki A, Fukutomi Y, Shiraishi Y, Toyotome T, Fukunaga K, Shimoda T, Konno S, Taniguchi M, Tomomatsu K, Okada N, Asano K; Japan ABPM Research Program.
Clinical and Translational Allergy.2024 JAN .;14:e12327

17）Anisakis allergy versus gastric anisakiasis: A case of repeated Anisakis-associated symptoms
Hamada Y, Sugano S, Kamide Y, Sekiya K, Fukutomi Y.
Journal of Allergy and Clinical Immunology: Global.2024 JAN.;3:100207

18）Treatable Traits in Asthma: The importance of extra- pulmonary traits - GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
McDonald VM, Hamada Y, Agusti A, Gibson PG
Journal of Allergy and Clinical Immunology: In Practice. 2024 JAN； Epub 2024 Jan 24.

19）A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19
Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, Kobayashi S, Kobayashi M, Shimada D, Natsume I, Kawasaki T, Ohba T, Tajiri S, Sakamaki F, Mineshita M, Takihara T, Sekiya K, Tomii K, Tomioka H, Kita H, Nishizaka Y, Fukui M, Miyata T, Harigae H.
Scientific Reports. 2024 Jan 2;14(1):165.

20）Reduction in ANCA levels associated with mepolizumab add-on treatment in eosinophilic granulomatosis with polyangiitis: Case series and literature review.
Kamide Y, Watai K, Nakamura Y, Iwata M, Fukutomi Y, Taniguchi M, Sekiya K.
Allergol Int. 2024 Jan;73(1):180-183.

21）Increased allergic episodes induced by Japanese apricot following the Cupressaceae pollen season in adult patients mono-sensitized to Pru p 7.
Hamada Y, Maruyama N, Saito A, Iwata M, Nakamura Y, Kamide Y, Sekiya K, Lidholm J, Fukutomi Y.
Allergol Int. 2024 Jan;73(1):168-170

22）Effects of raw seafood on the risk of hypersensitivity reaction recurrence in patients with an Anisakis allergy: A retrospective observational study in Japan.
Hamada Y, Nakatani E, Watai K, Iwata M, Nakamura Y, Ryu K, Kamide Y, Sekiya K, Fukutomi Y.
Allergol Int. 2024 Jan;73(1):171-173.

23）Uncovering severe patient group with pollen-related extrarespiratory allergic symptoms: A year-long diary survey in Japan
Fukutomi Y, Tanaka H, Sekiya K, Watai K, Hamada Y, Iwata M, Saito A, Okabe K, Sugiyama A, Fukushima T, Oshikawa C, Uetake H, Yoshisue H, Irie T, Kishikawa R.
The Journal of Allergy and Clinical Immunology: In Practice. 2024 Feb 19:S2213-2198(24)00167-3.

24）Metagenomic gut microbiome analysis of Japanese patients with multiple chemical sensitivity/idiopathic environmental intolerance
Watai K, Suda W, Kurokawa R, Sekiya K, Hayashi H, Iwata M, Nagayama K, Nakamura Y, Hamada Y, Kamide Y, Fukutomi Y, Nakabayashi T, Tanaka K, Kamita M, Taniguchi M, Hattori M.
BMC Microbiology. 2024 Mar 11;24(1):84.

2022.4～2023.3 

1）Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment.
Ueda S, Miura K, Kawasaki H, Ogata S, Yamasaki N, Miura S, Mori A, and Kaminuma O
Biomolecules 2022 May,;12(5):674

2）Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)population
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M
Allergology International. 2023 Jan;72(1):63-74.

3）Decreased expression of airway epithelial Axl is associated with eosinophilic inflammation in severe asthma
Itakura K, Fujino N, Kamide Y, Saito I, Yamada M, Okutomo K, Tsukita Y, Saito T, Ichikawa T, Numakura T, Kyogoku Y, Aizawa H, Ono Y, Matsumoto S, Hussell T, Taniguchi M, Ichinose M, Sugiura H.
Allergology International.2022 Jul.;71(3)383-394

4）Identification of asthma cases in Japan using health insurance claims data: Positive and negative predictive values of proposed discrimination criteria: A single-center study
Hamada Y, Nakatani E, Nagahama T, Nagai K, Nagayama K, Tomita Y, Sekiya K, Taniguchi M, Fukutomi Y.
Allergology International. 2023 Jan.;72(1):75-81.

5）Identification of fungi causing humidifier lung: 2 rare cases and a review of the literature
Ryu K, Fukutomi Y, Sekiya K, Saito A, Hamada Y, Watai K, Kamide Y, Taniguchi M, Araya J, Kuwano K, Kamei K.
Asia Pacific Allergy.2022 Oct.;12(4):e43

6）Re-evaluation of over-the-counter histamine H1-receptor antagonists based on their effects on murine models of allergen-induced nasal hyperresponsiveness
Uda N, Ogata S, Yamasaki N, Miura S, Hosomi N, Mori A, Gotoh M, Miura K, Kaminuma O
Journal of Pharmacological Sciences.2022 Oct.; 150(4): 275-278

7）The role of omalizumab in NSAID-exacerbated respiratory disease: a narrative review
Taniguchi M, Heffler E, Olze H, White A, Côrte-Real J, Olsson P, Lazarewicz S
The Journal of Allergy and Clinical Immunology. InPractice.2022Oct;10(10):2570-2578

8）Treatments of refractory eosinophilic lung diseases with biologics
Asano K, Suzuki Y, Tanaka J, Kobayashi K, Kamide Y
Allergology International.2022 Nov.; S1323-8930(22): 00121-6

9）Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems
Koga Y, Kamide Y, Hisada T, Ishizuka T.
Frontiers in Pharmacology.2023 Jan.;14:1037610

10）Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study
Hosoya K, Komachi T, Masaki K, Suzaki I, Saeki H, Kanda N, Nozaki M, Kamide Y, Matsuwaki Y, Kobayashi Y, Ogino E, Osada SI, Usukura N, Kurumagawa T, Ninomia J, Asako M, Nakamoto K, Yokoi H, Ohyama M, Tanese K, Kanzaki S, Fukunaga K, Ebisawa M, Okubo K.
Patient Preference and Adherence. 2023 Mar 27;17:861-872.

2021.4～2022.3 

1）New Clinical Diagnostic Criteria for Allergic Bronchopulmonary Aspergillosis/Mycosis and its Validation
Asano K, Hebisawa A, Ishiguro T, Takayanagi N, Nakamura Y, Suzuki J, Okada N, Tanaka J, Fukutomi Y, Ueki S, Fukunaga K, Konno S, Matsuse H, Kamei K, Taniguchi M, Shimoda T, Oguma T; Japan ABPM research program.
Journal of Allergy and Clinical Immunology.2021 Apr.;147(4):1261-1268

2）Occupational Hypersensitivity Pneumonitis in a Japanese Citrus Farmer
Kutsuzawa N, Takihara T, Shiraishi Y, Kajiwara H, Imanishi T, Fukutomi Y, Kamei K, Takahashi M, Enokida K, Horio Y, Ito Y, Hayama N, Oguma T, Asano K.
Internal Medicine.May.; 2021 Nov.;60(22):3581-3584. Epub 2021 May 22

3）Respiratory sensitization to insect allergens: Species, components and clinical symptoms
Fukutomi Y, Kawakami Y.
Allergology International.2021 Jul.;70(3):303-312

4) Genome-wide association study reveals an association between the HLA-DPB1 ∗ 02:01:02 allele and wheat-dependent exercise-induced anaphylaxis
Fukunaga K, Chinuki Y, Hamada Y, Fukutomi Y, Sugiyama A, Kishikawa R, Fukunaga A, Oda Y, Ugajin T, Yokozeki H, Harada N, Suehiro M, Hide M, Nakagawa Y, Noguchi E, Nakamura M, Matsunaga K, Yagami A, Morita E, Mushiroda T.
Am J Hum Genet. 2021 Aug.;108(8):1540-1548. Epub 2021 Jul 10.

5）Suppressive effect of dexamethasone on murine Th9 cell-mediated nasal eosinophilic inflammation.
Koyama T, Miura K, Yamasaki N, Ogata S, Ito D, Saeki M, Hiroi T, Mori A, Kaminuma O
Asia Pacific Allergy.2021 Jul.;11(3):e25

6）L-type amino acid transporter 1 inhibitor suppresses murine Th2 cell-mediated bronchial hyperresponsiveness independently of eosinophil accumulation.
Ito D, Miura K, Saeki M, Yamasaki N, Ogata S, Koyama T, Hiroi T, Mori A, Endou H, Hayashi K, Kaminuma O
Asia Pacific Allergy.2021 Jul.;11(3):e23

7）Eosinophil ETosis-mediated release of galectin-10 in eosinophilic granulomatosis with polyangiitis
Fukuchi M,Kamide Y,Ueki S,Miyabe Y,Konno Y,Oka N,Takeuchi H,Koyota S,Hirokawa M,Yamada T,C N Melo R,F Weller P,Taniguchi M
Arthritis & Rheumatology. 2021 Sep.;73(9):1683-1693

8）Prevalence of inhaled allergen-specific IgE antibody positivity in the healthy Japanese population
Tanaka J, Fukutomi Y, Shiraishi Y, Kitahara A, Oguma T, Hamada Y, Watai K, Nagai T, Taniguchi M, Asano K.
Allergology International. 2022 Jan.;71(1):117-124. Epub 2021 Sep 1.

9）Association between the severity of chronic spontaneous urticaria and sleep-disordered breathing
Nagayama K, Watai K, Sekiya K, Iwata M, Hashimoto Y, Nakamura Y, Miyake A, Ryu K, Hayashi H, Ohmatsu H, Kamide Y, Fukutomi Y, Taniguchi M
Allergology International. 2022 Jan.;71(1):103-108. Epub 2021 Sep 10.

10）Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis
Nakamura Y, Fukutomi Y, Sekiya K, Kajiwara K, Kawasaki Y, Fujita N, Nagayama K, Iwata M, Iwamoto K, Yano K, Hamada Y, Watai K, Ryu K, Hayashi H, Kamide Y, Taniguchi M.
Modern Rheumatology. 2022 Feb.;32(2):387-395.

11）Structure-based prediction of the IgE epitopes of the major dog allergen Can f 1.
Nakatsuji M, Sugiura K, Suda K, Sakurai M, Ubatani M, Muroya H, Okubo R, Noguchi R, Kamata Y, Fukutomi Y, Ishibashi O, Nishimura S, Inui T.
The FEBS Jounal. 2022 Mar.;289(6):1668-1679. Epub 2021 Nov 7.

12）Increased Prevalence of Atopic Dermatitis in Children Aged 0-3 Years Highly Exposed to Parabens
Arafune J, Tsujiguchi H, Hara A, Shimizu Y, Hori D, Nguyen TTT, Suzuki F, Hamagishi T, Yamada Y, Nakamura H, Yoshikawa T, Hayashi K, Shibata A, Fukutomi Y, Ohya Y, Yamamoto-Hanada K, Muto G, Hirota R, Konoshita T, Kambayashi Y, Nakamura H.
International Journal of Environmental Research and Public Health.2021 Nov.;18(21):11657

13）The First Death in Japan Attributed to COVID-19:A Brief Report
Nagayama K，Watai K，Sekiya K，Kamide Y，Kaneda G
Cureus. 2021 Dec.;13(12):e20721

14）Miliary pattern on chest imaging caused by adenocarcinoma
Hamada Y, Iwata M, Sekiya K
CMAJ.2022 Feb.;194(7):E259-E260

15）Allergic fungal diseases in theupper and lower airways
Shigeharu U, Fukutomi Y, Miyabe Y，Yamada T,Oguma T，and Asano K
Eosinophilic Lung Diseases (ERS Monograph).2022 Mar.;:119–140

16）Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis
Koga Y, Aoki-Saito H, Kamide Y, Sato M, Tsurumaki H, Yatomi M, Ishizuka T, Hisada T.
Frontiers in Pharmacology.2022 Mar.;13:865318

■Allergic disease（Child）

2023.4～2024.3

1）Differential patterns of fish sensitization in Asian populations: Implication for precision diagnosis
Wai CYY, Leung NYH, Leung ASY, Fusayasu N, Sato S, Xu KJY, Yau YS, Rosa Duque JS, Kwan MYW, Cheng JWCH, Chan WH, Chua GT, Lee QU, Luk DCK, Ho PK, Wong JSC, Lam ICS, Wong GWK, Ebisawa M, Leung TF
Allergology International . 2023 Jul;72(3):458-465. Epub 2023 Apr 7.

2）Analysis of drug-induced anaphylaxis cases using the Japanese Adverse Drug Event Report (JADER) database - secondary publication Sugizaki C, Sato S, Yanagida N, Ebisawa M
Allergology International . 2023 Oct;72(4):580-587. Epub 2023 Apr 12.

3) Randomized controlled trial of slow peanut oral immunotherapy in young children: SmaChO study protocol
Uhl C, Sverremark-Ekström E, Borres M, Ebisawa M, Melén E, Mäkelä MJ, Konradsen JR, Vickery BP, Asarnoj A, Nilsson C
Clinical & Experimental Allergy . 2023 May;53(5):594-597. Epub 2023 Apr 26.

4）Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis
Pouessel G, Deschildre A, Dribin TE, Ansotegui IJ, Cardona V, Chinthrajah RS, Ebisawa M, Muraro A, Roberts G, Sampson HA, Waserman S, Wood RA, Worm M, Turner PJ
The Journal of Allergy and Clinical Immunology: In Practice . 2023 Jul;11(7):2043-2048. Epub 2023 May 10.

5）Specific IgE to individual allergen components: Milk and egg
Sato S, Ebisawa M
Elsevier Reference Collection in Food Science.2023 Jun 1

6）Relationship between eliciting doses and the severity of allergic reactions to food
Yanagida N, Sato S, Ebisawa M
Current Opinion in Allergy and Clinical Immunology . 2023 Jun 1;23(3):226-232. Epub 2023 Mar 28.

7）Food allergy: new therapeutic options open deeper questions
Fiocchi A, Ebisawa M
Current Opinion in Allergy and Clinical Immunology . 2023 Jun 1;23(3):216-217.

8）Optimization of the allergen classification of the International Classification Of Diseases, 11th Revision (ICD-11)
Tanno LK, Briand Y, Mary M, Khan DA, Sublett JL, Corbett ML, Pawankar R, Del Giacco S, Torres MJ, Ansontegui IJ, Ebisawa M, Martin B, Demoly P
Journal of Allergy and Clinical Immunology . 2023 Jun;151(6):1655-1659.e3. Epub 2023 Apr 4.

9）A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity
Kallen EJJ, Revers A, Fernández-Rivas M, Asero R, Ballmer-Weber B, Barreales L, Belohlavkova S, de Blay F, Clausen M, Dubakiene R, Ebisawa M, Fernández-Perez C, Fritsche P, Fukutomi Y, Gislason D, Hoffmann-Sommergruber K, Jedrzejczak-Czechowicz M, Knulst AC, Kowalski ML, Kralimarkova T, Lidholm J, Metzler C, Mills ENC, Papadopoulos NG, Popov TA, Purohit A, Reig I, Seneviratne SL, Sinaniotis A, Takei M, Versteeg SA, Vassilopoulou AE, Vieths S, Welsing PMJ, Zwinderman AH, Le TM, Van Ree R
Allergy . 2023 Sep;78(9):2497-2509. Epub 2023 Jun 19.

10）Hospital oral food challenge tests in the coronavirus disease 2019 pandemic: A nationwide survey
Yanagida N, Sugizaki C, Sato S, Ebisawa M
Clinical and Translational Allergy . 2023 Jul;13(7):e12273.

11）Effect of Maternal Egg Intake During the Early Neonatal Period and Risk of Infant Egg Allergy at 12 Months Among Breastfeeding Mothers: A Randomized Clinical Trial
Nagakura KI, Sato S, Shinahara W, Kido H, Fujita H, Yanai T, Akiyama N, Futamura M, Koga H, Fujiwara M, Kaneko H, Taniguchi H, Makita E, Takahashi K, Yanagida N, Ebisawa M, Urashima M
JAMA Network Open . 2023 Jul 3;6(7):e2322318.

12）Update on oral and epicutaneous immunotherapy for children with food allergy
Miura Y, Sato S, Yanagida N, Ebisawa M
Allergo Journal International.2023 Jul 11

13）Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series
Hara S, Itonaga T, Nishino M, Yanagida N, Sato S, Ebisawa M
Journal of Allergy and Clinical Immunology: Global. 2023 Mar 21;2(2):100096.

14）Rapid increases in epinephrine concentration following presumed intra-blood vessel administration via epinephrine autoinjector
Ebisawa M, Kaliner MA, Lowenthal R, Tanimoto S.
Journal of Allergy and Clinical Immunology: Global . 2023 May 23;2(3):100118

15）Pediatric Allergy and Immunology (PAI) is for polishing with artificial intelligence, but careful use.
Eigenmann P, Akenroye A, Atanaskovic Markovic M, Candotti F, Ebisawa M, Genuneit J, Kalayci Ö, Kollmann D, Leung ASY, Peters RL, Riggioni C.
Pediatric Allergy and Immunology. 2023 Sep;34(9):e14023.

16）Analysis of the Factors That Affect the Detection Duration of SARS-CoV-2 in Loop Mediated Isothermal Amplification among COVID-19 Inpatients
Maruyama K，Sekiya K，Yanagida N，Nakayama K，Kushida Y，Yasuda S，Fukumoto D，Hosoya S，Moriya H， Katsumi M
Japanese Journal of Infectious Diseases. 2023 Sep 22;76(5):282-288. Epub 2023 May 31.

17）Long-term prognosis after low-dose peanut challenge for patients with a history of anaphylaxis
Akamatsu N, Nagakura KI, Sato S, Yanagida N, Ebisawa M
Pediatric Allergy and Immunology. 2023 Oct;34(10):e14031.

18）EAACI guidelines on the diagnosis of IgE-mediated food allergy
Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, Alvaro-Lozano M, Ballmer-Weber B, Barni S, Beyer K, Bindslev-Jensen C, Brough HA, Buyuktiryaki B, Chu D, Del Giacco S, Dunn-Galvin A, Eberlein B, Ebisawa M, Eigenmann P, Eiwegger T, Feeney M, Fernandez-Rivas M, Fisher HR, Fleischer DM, Giovannini M, Gray C, Hoffmann-Sommergruber K, Halken S, Hourihane JO, Jones CJ, Jutel M, Knol E, Konstantinou GN, Lack G, Lau S, Marques Mejias A, Marchisotto MJ, Meyer R, Mortz CG, Moya B, Muraro A, Nilsson C, Lopes de Oliveira LC, O'Mahony L, Papadopoulos NG, Perrett K, Peters RL, et al.
Allergy . 2023 Dec;78(12):3057-3076. Epub 2023 Oct 10.

19）Global disparities in availability of epinephrine auto-injectors
Tanno LK, Worm M, Ebisawa M, Ansotegui IJ, Senna G, Fineman S, Geller M, Gonzalez-Estrada A, Campbell DE, Leung A, Muraro A, Levin M, Ortega Martell JA, Caminati M, Kolkhir P, Le Pham D, Darlenski R, Esteban-Gorgojo I, Rial M, Filipovic I, Chiarella SE, Cuervo-Pardo L, Kwong C, Pozo-Beltran CF, Trinh TH, Greenberger PA, Turner PJ, Thong BY, Martin B, Cardona V; WAO Anaphylaxis Committee and the WAO Junior Members Steering Group.
World Allergy Organization Journal. 2023 Oct 20;16(10):100821

20）Safe consumption of processed foods after negative medium-dose cow's milk oral food challenge
Koosakulchai V, Park S, Ban M, Fusayasu N, Yanagida N, Sato S, Ebisawa M
Allergology International. 2023 Oct 30:S1323-8930(23)00108-9.

21）Real-world compliance and determinants for sublingual allergen immunotherapy in children and parents
Okubo Y, Kuwabara Y, Sato S, Sakashita M, Yuka H, Morita H
Allergy. 2023 Nov 2.

22）World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update - X - Breastfeeding a baby with cow's milk allergy
McWilliam V, Netting MJ, Volders E, Palmer DJ; WAO DRACMA Guideline Group (Ebisawa18 et al.)
World Allergy Organization Journal. 2023 Nov 3;16(11):100830.

23）Impact of COVID-19 on care-seeking patterns for hay fever in Japan: A retrospective claims database cohort study
Akasaki Y, Iwagami M, Sung J, Nagino K, Adachi T, Morita H, Tamari M, Kainuma K, Kan-o K, Ogata H, Sakashita M, Futamura M, Kurashima Y, Nakajima S, Masaki K, Ogawa Y, Sato S, Miyagawa A, Midorikawa-Inomata A, Fujimoto K, Okumura Y, Fujio K, Huang T, Hirosawa K, Morooka Y, Nakao S, Murakami A, Kobayashi H, Inomata T
Allergy. 2023 Nov 15.

24）The utility of macadamia nut legumin Mac i 2 and its conformational epitopes in the diagnosis of macadamia nut allergy
Yamamoto R, Ando T, Kitaura J, Narita M, Miura K, Takasato Y, Nagao M, Okumura K, Ogawa H, Ohnishi H, Watanabe T, Ito K, Fujisawa T, Ebisawa M, Ohya Y, Kabasser S, Bublin M, Yasudo H
The Journal of Allergy and Clinical Immunology: In Practice. 2023 Nov 19:S2213-2198(23)01261-8.

25）Natural history of cow's milk allergy in children aged 6-12 years
Kubota K, Nagakura KI, Ejiri Y, Sato S, Ebisawa M, Yanagida N
Pediatric Allergy and Immunology. 2023 Dec;34(12):e14064.

26）Adrenaline auto injectors pharmacokinetic/pharmacodynamic studies and potential consequences for clinical practice
Worm M, Fox AT, Wickman M, Ring J, Ebisawa M, Pouessel G, Smith P
Clinical and Translational Allergy. 2023 Dec;13(12):e12323.

27）Reaching Communities Through Food Allergy Advocacy, Research, and Education: A Comprehensive Analysis.
Sansweet S, Rolling C Jr, Ebisawa M, Wang J, Gupta R, Davis CM
Journal of Allergy and Clinical Immunology: In Practice. 2023 Dec 25:S2213-2198(23)01389-2.

28）Editorial comment on "Oral immunotherapy as a curative treatment for food-allergic preschool children: Current evidence and potential underlying mechanisms"
Arasi S, Ebisawa M, Eigenmann P, Dinardo G
Pediatric Allergy and Immunology. 2024 Jan;35(1):e14071.

29）Three-year prognosis after low-dose oral food challenge for children with wheat allergy
Itonaga T, Yanagida N, Nagakura KI, Asaumi T, Tokunaga M, Nishino M, Takahashi K, Ogura K, Sato S, Ebisawa M
Allergology International. 2024 Jan 31:S1323-8930(24)00005-4.

30）Editorial comment on "Frequency of fatal and recurrent anaphylaxis due to cow's milk: A systematic review and meta-analysis of observational studies"
Sousa-Pinto B, Alvarez-Perea A, Ebisawa M, Eigenmann P
Pediatric Allergy and Immunology. 2024 Feb;35(2):e14088.

31）Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee
Turner PJ, Ansotegui IJ, Campbell DE, Cardona V, Carr S, Custovic A, Durham S, Ebisawa M, Geller M, Gonzalez-Estrada A, Greenberger PA, Hossny E, Irani C, Leung ASY, Levin ME, Muraro A, Oppenheimer JJ, Ortega Martell JA, Pouessel G, Rial MJ, Senna G, Tanno LK, Wallace DV, Worm M, Morais-Almeida M; WAO Anaphylaxis Committee and WAO Allergen Immunotherapy Committee.
World Allergy Organization Journal. 2024 Feb 10;17(3):100876.

32）Timing of initial symptom onset during milk and wheat challenges: A retrospective study
Yanagida N, Minoura T, Sato S, Takahashi K, Nagakura KI, Ogura K, Itonaga T, Miura Y, Fusayasu N, Ebisawa M.
Immunity, Inflammation and Disease. 2024 Feb;12(2):e1174.

33）Authors' response
Tanimoto S, Kaliner M, Lockey R, Ebisawa M
Annals of Allergy, Asthma & Immunology.2024 Mar.;132(3):402

34）Disparities in pediatric anaphylaxis triggers and management across Asia
Leung ASY, Tham EH, Pacharn P, Xing Y, Trinh HKT, Lee S, Ahn K, Chatchatee P, Sato S, Ebisawa M, Lee BW, Wong GWK; Asia-Pacific Research Network for Anaphylaxis (APRA)
Allergy. 2024 Mar 10.

35）Precision allergy molecular diagnosis applications in food allergy
Sato S, Ebisawa M
Current Opinion in Allergy and Clinical Immunology. 2024 Mar 27.

36）Management of food allergy based on oral food challenge
Ishibashi S, Yanagida N, Sato S, Ebisawa M
Current Opinion in Allergy and Clinical Immunology. 2024 Mar 28.

37）Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent.
Mack DP, Dribin TE, Turner PJ, Wasserman RL, Hanna MA, Shaker M, Tang MLK, Rodríguez Del Río P, Sobolewski B, Abrams EM, Anagnostou A, Arasi S, Bajowala S, Bégin P, Cameron SB, Chan ES, Chinthrajah S, Clark AT, Detjen P, du Toit G, Ebisawa M, Elizur A, Factor JM, Greiwe J, O'B Hourihane J, Hughes SW, Jones DH, Muraro A, Nowak-Wegrzyn A, Patel NB, Scurlock AM, Shah AN, Sindher SB, Tilles S, Vickery BP, Wang J, Windom HH, Greenhawt M.
Journal of Allergy and Clinical Immunology. 2024 Mar 28:S0091-6749(24)00238-0.

2022.4～2023.3

1）Recent advances in diagnosing and managing nut allergies with focus on hazelnuts, walnuts, and cashew nuts
Borres MP, Sato S, Ebisawa M
World Allergy Organization Journal.2022 Apr.;15(4): 100641

2）World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update - XIV - Recommendations on CMA immunotherapy.
Brozek JL, Ebisawa M, et al
World Allergy Organization Journal.2022 Apr.;15(4): 100646

3）Long-term follow-up of fixed low-dose oral immunotherapy for children with wheat-induced anaphylaxis
Nagakura KI, Yanagida N, Miura Y, Itonaga T, Nishino M, Takahashi K, Ogura K, Sato S, Ebisawa M
J Allergy Clin Immunol Pract. 2022 Apr; 10(4):1117-1119.e2. Epub 2021 Dec 23.

4）Is oral food challenge test useful for avoiding complete elimination of cow's milk in Japanese patients with or suspected of having IgE-dependent cow's milk allergy?
Maeda M, Kuwabara Y, Tanaka Y, Nishikido T, Hiraguchi Y, Yamamoto-Hanada K, Okafuji I, Yamada Y, Futamura M, Ebisawa M.
Allergology International. 2022 Apr; 71(2):214-220. Epub 2021 Sep 27.

5）Is oral food challenge useful to avoid complete elimination in Japanese patients diagnosed with or suspected of having IgE-dependent hen's egg allergy? A systematic review
Murai H, Irahara M, Sugimoto M, Takaoka Y, Takahashi K, Wada T, Yamamoto-Hanada K, Okafuji I, Yamada Y, Futamura M, Ebisawa M.
Allergology International. 2022 Apr; 71(2):221-229. Epub 2021 Oct 16.

6）History of immediate reactions changes the predictive accuracy for pediatric peanut allergy
Fusayasu N, Asaumi T, Takahashi K, Nagakura KI, Nishino M, Sato S, Yanagida N, Ebisawa M.
Allergology International. 2022 Apr; 71(2):248-250. Epub 2021 Oct 18.

7）Capsicum Allergy: Involvement of Cap a 7, a New Clinically Relevant Gibberellin-Regulated Protein Cross-Reactive With Cry j 7, the Gibberellin-Regulated Protein From Japanese Cedar Pollen
Takei M, Nin C, Iizuka T, Pawlikowski M, Selva MA, Chantran Y, Nakajima Y, Zheng J, Aizawa T, Ebisawa M, Sénéchal H, Poncet P.
Allergy Asthma Immunology Research.2022 May.; 14(3):328-338

8）Editorial comments on: "Food allergy in early childhood increases the risk of pollen food allergy syndrome".
Eigenmann P, Ebisawa M.
Pediatr Allergy Immunol.2022 May.; 33(5): e13788

9）WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19.
Rouadi PW, Ebisawa M, et al
World Allergy Organization Journal.2022 May.; 15(5): 100649

10）Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement.
Alvarez-Cuesta E, et al, Collaborators:Ebisawa M, et al
World Allergy Organization Journal.2022 May.; 15(6): 100640

11）Research impact analysis of international funding agencies in the realm of allergy and immunology
Adachi T,Sato S, et al
Allergy. 2022 May.;77(5):1602-1606. Epub 2022 Feb 16.

12）Predictive value of 7S globulin-specific IgE in Japanese macadamia nut allergy patients
Yasudo H,Ebisawa M, et al
J Allergy Clin Immunol Pract. 2022 May.;10(5):1389-1391.e1. Epub 2022 Jan 21.

13）Personalized management for unmet needs with food allergy.
Miura Y, Yanagida N, Sato S, Ebisawa M.
Curr Opin Allergy Clin Immunol. 2022 Jun.; 22(3): 160-166

14）One-year safety and tolerability of tezepelumab in Japanese patients with severe uncontrolled asthma: results of the NOZOMI study.
Shinkai M, Ebisawa M, Fukushima Y, Takeuchi S, Okada H, Tokiyo T, Hayashi N, Takikawa M, Colice G, Almqvist G.
J Asthma. 2023 Mar.;60(3):616-624.Epub 2022 Jun 16.

15）Presentation of airway and general symptoms in Covid-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus
Hagemann J,et al. , ARIA group: Ebisawa M, et al.
Allergy. 2022 Jun.; 10.1111/all.15416

16）Proposal of 0.5mg of protein /100g of processed food as threshold for voluntary declaration of food allergen traces in processed food - a first step in an initiative to better inform patients and avoid fatal allergic reactions - A GA²LEN position paper
Zuberbier T, Ebisawa M et al
Allergy. 2022 Jun.; 77(6):1736-1750. Epub 2021 Nov 24.

17）Cashew allergy diagnosis: a two-step algorithm leads to fewer oral food challenges
Brettig T, Koplin JJ, Dang T, Lange L, McWilliam V, Sato S, Savvatianos S, Perrett KP
J Allergy Clin Immunol Pract.2022 Jun;10(6):1652-1654.e2. Epub 2022 Jan 21.

18）Cross-reactivity of each fraction among cereals in children with wheat allergy.
Takei M, Saito A, Yanagida N, Sato S, Ebisawa M.
Pediatr Allergy Immunol. 2022 Jul.; 33(7): e13831

19）Diversities of allergic pathologies and their modifiers: Report from the second DGAKI-JSA meeting.
Asano K, Tamari M, Zuberbier T, Yasudo H, Morita H, Fujieda S, Nakamura Y, Traidl S, Hamelmann E, Raap U, Babina M, Nagase H, Okano M, Katoh N, Ebisawa M, Renz H, Izuhara K, Worm M.
Allergol Int. 2022 Jul.; 71(3): 310-317

20）Threshold and safe ingestion dose among infants sensitized to hen's egg.
Mitomori M, Yanagida N, Nishino M, Takahashi K, Nagakura KI, Ogura K, Takei M, Sato S, Ebisawa M.
Pediatr Allergy Immunol. 2022 Jul.; 33(7): e13830

21）Evaluation of adrenaline auto-injector prescription profiles: Apopulation-based, retrospective cohort study within the NationalInsurance Claims Database of Japan
Sato S, et al
Allergology International. 2022 Jul.; 71(3):354-361. Epub 2022 Mar 21.

22）Ana o 3 sIgE and diagnostic algorithms reduce cost of cashew allergy diagnosis in children compared with skin prick test: A cost comparison analysis
Brettig T, Dalziel K, Koplin JJ, Dang T, Lange L, McWilliam V, Sato S, Savvatianos S, Perrett KP.
Pediatric Allergy and Immunology.2022 Aug.; 33(8):

23）Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study.
Ishizuka T, Menzies-Gow A, Okada H, Fukushima Y, Hayashi N, Colice G, Ponnarambil S, Hunter G, Odajima H, Ebisawa M.
Allergol Int. 2022 Aug.; S1323-8930(22): 00082-X

24）COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations
Jutel M, Ebisawa M, et al
Allergy. 2022 Aug.; 77(8):2313-2336. Epub 2022 Mar 18.

25）Macadamia nut-specific IgE levels for predicting anaphylaxis.
Kubota K, Nagakura KI, Itonaga T, Sato S, Ebisawa M, Yanagida N.
Pediatr Allergy Immunol. 2022 Sep.; 33(9): e13852

26）Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study.
Tohda Y, Nakamura Y, Fujisawa T, Ebisawa M, Msihid J, Djandji M, Ortiz B, Jacob-Nara JA, Deniz Y, Rowe PJ, Ishida M, Arima K.
PAllergol Int. 2022 Sep.; 13:S1323-8930(22): 00087-9

27）Managing food allergy: GA2LEN guideline 2022.
Muraro A, Ebisawa M et al.
World Allergy Organization Journal. 2022 Sep.; 15(9): 100687

28）World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XIII - Oral immunotherapy for CMA - Systematic review.
Bognanni A, et al.,WAO DRACMA Guideline Group:Ebisawa M, et al
World Allergy Organization Journal. 2022 Sep.; 15(9): 100682

29）Systematic review of monotherapy with biologicals for children and adults with IgE-mediated food allergy.
de Silva D, Singh C, Arasi S, Muraro A, Zuberbier T, Ebisawa M, Alvaro Lozano M, Roberts G.
Clin Transl Allergy. 2022 Sep.; 12(9): e12123

30）Updated threshold dose-distribution data for sesame.
Turner PJ, Gretzinger M, Patel N, Brough H, Chinthrajah RS, Ebisawa M, Elizur A, Koplin JJ, Peters RL, Purington N, Nowak-Wegrzyn A, Saf S, Sampson HA, Westerhout J, Blom WM, Baumert JL, Houben GF, Remington BC.
Allergy. 2022 Oct.; 77(10): 3124-3162

31）Updated full range of Eliciting Dose values for Cow's milk for use in food allergen risk assessment.
TBlom WM, Westerhout J, Baumert JL, Meima MY, Turner PJ, Ebisawa M, Yanagida N, Remington BC, Houben GF.
Food Chem Toxicol. 2022 Oct.; 168: 113381

32）Editorial Comment on: The role of short-term grass pollen exposure in food skin-prick test reactivity, food allergy, and eczema flares in children.
Ebisawa M, Eigenmann P.
Pediatr Allergy Immunol. 2022 Oct.; 33(10): e13866

33）Risk Factors for Lung Function Decline in Pediatric Asthma under Treatment: A Retrospective, Multicenter, Observational Study.
Yamada S, Fujisawa T, Nagao M, Matsuzaki H, Motomura C, Odajima H, Nakamura T, Imai T, Nagakura KI, Yanagida N, Mitomori M, Ebisawa M, Kabashima S, Ohya Y, Habukawa C, Tomiita M, Hirayama M.
Children (Basel). 2022 Oct.; 9(10): 1516

34）Phenotyping of immediate-type food allergies based on 10 years of research: A latent class analysis
Takahashi K, Yanagida N, Itonaga T, Nishino M, Nagakura KI, Ogura K, Sato S, Ebisawa M
Pediatric Allergy and Immunology.2022 Nov.; 33(11): 13873

35）Clinical cross-reactivity of wheat and barley in children with wheat allergy
Yanagida N, Takei M, Saito A, Sato S, Ebisawa M.
Pediatric Allergy and Immunology.2022 Nov.; 33(11): 13878

36）Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Sousa-Pinto B, Ebisawa M, et al
Clinical and Translational Allergy.2022 Nov.; 12(11): e12208

37）Pharmacokinetic and Pharmacodynamic Comparison of Epinephrine administered intranasally and intramuscularly: an integrated analysis.
Tanimoto S, Kaliner M, Lockey RF, Ebisawa M, Koplowitz LP, Koplowitz B, Lowenthal R.
Ann Allergy Asthma Immunol. 2022 Nov.; S1081-1206(22): 01904-4

38）Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: An integrated analysis
Tanimoto S, Kaliner M, Lockey RF, Ebisawa M, Koplowitz LP, Koplowitz B, Lowenthal R
Annals of Allergy, Asthma & Immunology.2022 Nov.; S1081-1206(22): 01904-4

39）Risk factors for failing a repeat oral food challenge in preschool children with hen's egg allergy.
Nishino M, Yanagida N, Sato S, Nagakura KI, Takahashi K, Ogura K, Ebisawa M
Pediatric Allergy and Immunology.2022 Dec.; 33(12): e13895

40）Sensitization to macadamia 7S globulin amino-terminus with clinical relevance in Japanese children with macadamia nut allergy
Ando T, Kitaura J, Maruyama N, Narita M, Miura K, Takasato Y, Nogami K, Nagao M, Okumura K, Ogawa H, Onishi H, Watanabe T, Ito K, Fujisawa T, Ebisawa M, Kawakami T, Matsumoto K, Hasegawa S, Ohya Y, Yasudo H
Allergology International.2022 Dec.; S1323-8930(22): 00130-7

41）Current situation of anaphylaxis in Japan: Data from the anaphylaxis registry of training and teaching facilities certified by the Japanese Society of Allergy - secondary publication.
Sato S, Yanagida N, Ito K, Okamoto Y, Saito H, Taniguchi M, Nagata M, Hirata H, Yamaguchi M, Pawankar R, Ebisawa M
Allergology International.2022 Dec.; S1323-8930(22): 00140-X

42）Varying Approaches to Management of IgE-Mediated Food Allergy in Children Around the World.
Lloyd M, Loke P, Mack DP, Sicherer SH, Perkin MR, Boyle R, Yin Leung AS, Lee BW, Levin M, Blumchen K, Fiocchi A, Ebisawa M, Oliveira LCL, Tang MLK.
Journal of Allergy and Clinical Immunology.2023 Feb.; S2213-2198(23): 00175-7

43）EAACI Molecular Allergology User's Guide 2.0
Dramburg S, Hilger C, Santos AF, de Las Vecillas L, Aalberse RC, Acevedo N, Aglas L, Altmann F, Arruda KL, Asero R, Ballmer-Weber B, Barber D, Beyer K, Biedermann T, Bilo MB, Blank S, Bosshard PP, Breiteneder H, Brough HA, Bublin M, Campbell D, Caraballo L, Caubet JC, Celi G, Chapman MD, Chruszcz M, Custovic A, Czolk R, Davies J, Douladiris N, Eberlein B, Ebisawa M, Ehlers A, Eigenmann P, Gadermaier G, Giovannini M, Gomez F, Grohman R, Guillet C, Hafner C, Hamilton RG, Hauser M, Hawranek T, Hoffmann HJ, Holzhauser T, Iizuka T, Jacquet A, Jakob T, Janssen-Weets B, Jappe U, Jutel M, Kalic T, Kam
Pediatric Allergy and Immunology. 2023 Mar;34 Suppl 28:e13854.

44）WAO consensus on DEfinition of Food Allergy SEverity (DEFASE).
Arasi S, Ebisawa M et al.
World Allergy Organization Journal.2023 Mar.; 16(3): 100753

45）Enhanced early skin treatment for atopic dermatitis in infants reduces food allergy
Yamamoto-Hanada K, Kobayashi T, Mikami M, Williams HC, Saito H, Saito-Abe M, Sato M, Irahara M, Miyaji Y, Ishikawa F, Tsuchiya K, Tamagawa-Mineoka R, Takaoka Y, Takemura Y, Sato S, Wakiguchi H, Hoshi M, Natsume O, Yamaide F, Seike M, Ohya Y; PACI Study investigators.
Journal of Allergy and Clinical Immunology. 2023 Jul;152(1):126-135. . Epub 2023 Mar 22.

46）Prognosis of infantile food protein-induced enterocolitis syndrome to wheat: A case series
Nishino M, Yanagida N, Sato S, Nagakura KI, Takahashi K, Ogura K, Ebisawa M.
Pediatric Allergy and Immunology. 2023 Mar;34(3):e13940.

47）Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study
Hosoya K, Komachi T, Masaki K, Suzaki I, Saeki H, Kanda N, Nozaki M, Kamide Y, Matsuwaki Y, Kobayashi Y, Ogino E, Osada SI, Usukura N, Kurumagawa T, Ninomia J, Asako M, Nakamoto K, Yokoi H, Ohyama M, Tanese K, Kanzaki S, Fukunaga K, Ebisawa M, Okubo K.
Patient Preference and Adherence. 2023 Mar 27;17:861-872.

48）Oral Immunotherapy in Food Allergy: Where Are We Now?
Özdemir PG, Sato S, Yanagida N, Ebisawa M.
Allergy, Asthma and Immunology Research. 2023 Mar;15(2):125-144.

49）Relationship between serum allergen-specific immunoglobulin E and threshold dose in an oral food challenge
Yanagida N, Sato S, Nagakura KI, Takahashi K, Fusayasu N, Miura Y, Itonaga T, Ogura K, Ebisawa M.
Pediatric Allergy and Immunology . 2023 Mar;34(3):e13926.

2021.4～2022.3

1) Food protein-induced enterocolitis syndrome triggered by egg yolk and egg white
Nishino M, Sato S, Nagakura KI, Takahashi K, Asaumi T, Ogura K, Ebisawa M, Yanagida N.
Pediatric Allergy and Immunology. 2021 Apr.;32(3):618-621. Epub 2020 Nov 29.

2) Timing of onset of allergic symptoms following low-dose milk and egg challenges
Yanagida N, Sato S, Takahashi K, Ohtani K, Emura S, Shibukawa Y, Murano A, Komata T, Ishida W, Fujita H, Asaumi T, Nagakura KI, Ogura K, Ebisawa M.
Pediatric Allergy and Immunology. 2021 Apr.;32(3):612-615. Epub 2021 Jan 13.

3) Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet J, Ebisawa M, et al
Pediatr Allergy. 2021 Oct.;76(10):2952-2964

4) Addressing risk management difficulties in children with food allergies
Eigenmann PA, Ebisawa M, Greenhawt M, Hourihane JO, Perry TT, Remington BC, Wood RA.
Pediatr Allergy Immunol.2021 May.;32(4):658-666

5) Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines
Waserman S, Cruickshank H, Hildebrand KJ, Mack D, Bantock L, Bingemann T, Chu DK, Cuello-Garcia C, Ebisawa M, Fahmy D, Fleischer DM, Galloway L, Gartrell G, Greenhawt M, Hamilton N, Hourihane J, Langlois M, Loh R, Muraro A, Rosenfield L, Schoessler S, Tang MLK, Weitzner B, Wang J, Brozek JL.
Journal of Allergy and Clinical Immunology.2021 May.;147(5):1561-1578.

6) Precision medicine reaching out to the patients in allergology - a German-Japanese workshop report
Pfaar O, Blumchen K, Boateng E, Hamelmann E, Iinuma T, Jakob T, Krauss-Etschmann S, Nagase H, Nakajima S, Nakano T, Renz H, Sato S, Taube C, Wagenmann M, Werfel T, Worm M, Izuhara K.
Japanese Journal of Infectious Diseases. 2021 May.;5:162-179.

7) Long-term follow-up of fixed low-dose oral immunotherapy for children with severe cow's milk allergy
Miura Y, Nagakura KI, Nishino M, Takei M, Takahashi K, Asaumi T, Ogura K, Sato S, Ebisawa M, Yanagida N.
Pediatr Allergy Immunol. 2021 May.;32(4):734-741. Epub 2021 Jan 24.

8) Loop-Mediated Isothermal Amplification for Diagnosing SARS-CoV-2 Infection in Two School Children and a Neonate
Kubota K, Nagakura KI, Ebisawa M, Kaneda G, Yanagida N.
Japanese Journal of Infectious Diseases. 2022 Jan.;75(1):86-88. Epub 2021 May 31.

9) The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management
Sánchez-Borges M, Ansotegui IJ, Baiardini I, Bernstein J, Canonica GW, Ebisawa M, Gomez RM, González-Diaz S, Martin B, Morais de Almeida M, Ortega Martell JA.
World Allergy Organization Journal.2021 Jun.;14(6):100533

10) The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations
Sánchez-Borges M, Ansotegui IJ, Baiardini I, Bernstein J, Canonica GW, Ebisawa M, Gomez RM, González-Diaz S, Martin B, Morais de Almeida M, Ortega Martell JA.
World Allergy Organization Journal.2021 Jun.;14(6):100546

11) Editorial: Food allergy: from defense to attack
Fiocchi A, Ebisawa M.
Current Opinion in Allergy and Clinical Immunology.2021 Jun.;21(3):261-262

12) ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
Bousquet J,Ebisawa M, et al
Clinical and Translational Allergy.2021 Jun.;11(4):e12014

13) Food-induced anaphylaxis morbidity: emergency department and hospitalizations data support preventive strategies
Tanno LK, Clark E, Mamodaly M, Cardona V, Ebisawa M, Asontegui I, Sanchez-Borges M, Santos AF, Fiocchi A, Worm M, Caimmi D, Latour Staffeld P, Muraro A, Pawankar R, Greenberger PA, Thong BY, Martin B, Demoly P.
Padiatric Allergy and Immunology 2021 Nov.;32(8):1730-1742. Epub 2021 Jul 21.

14) Erratum to "IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper" [World Allergy Organ J 13/2 (2020) 100080]
Ansotegui IJ, Ebisawa M et al
World Allergy Organization Journal.2021 Jun.;14(7):100557

15) Low-dose oral immunotherapy for walnut allergy with anaphylaxis: Three case reports
Sasamoto K, Nagakura KI, Sato S, Yanagida N, Ebisawa M
Allergol Int.2021 Jul.;70(3):392-394.

16) EAACI guideline: preventing the development of food allergy in infants and young children (2020 update)
Halken S, Muraro A, de Silva D, Khaleva E, Angier E, Arasi S, Arshad H, Bahnson HT, Beyer K, Boyle R, du Toit G, Ebisawa M, Eigenmann P, Grimshaw K, Hoest A, Jones C, Lack G, Nadeau K, O'Mahony L, Szajewska H, Venter C, Verhasselt V, Wong GW, Roberts G; European Academy of Allergy and Clinical Immunology Food Allergy and Anaphylaxis Guidelines Group.
Pediatr Allergy Immunol.2021 Jul.;32(5):843-858.

17) Gibberellin-regulated protein sensitization in Japanese cedar (Cryptomeria japonica) pollen allergic Japanese cohorts
Iizuka T, Takei M, Saito Y, Rumi F, Zheng J, Lu X, Chafey P, Broussard C, Guilloux L, Charpin D, Ebisawa M, Sénéchal H, Aizawa T, Poncet P
Allergy. 2021 Jul.;76(7):2297-2302. Epub 2021 Mar 28.

18) Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold- An ARIA-EAACI-GA2 LENconsensus
Hagemann J, Ebisawa M, et al
Allergy. 2021 Aug.; 76(8):2354-2366. Epub 2021 May 14.

19) Precision medicine for cow's milk immunotherapy in clinical practice
Miura Y, Nagakura KI, Sato S, Yanagida N, Ebisawa M.
Current Opinion in Allergy and Clinical Immunology.2021 Aug.;21(4):378-385

20) Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis
Turner PJ, Ebisawa M et al
J Allergy Clin Immunol Pract. 2022 Jan.;10(1):59-70. Epub 2021 Aug 23.

21) Low-dose oral immunotherapy for walnut allergy with anaphylaxis: Three case reports
Sasamoto K, Nagakura KI, Sato S, Yanagida N, Ebisawa M
Allergology International.2021 Jul.;70(3):392-394

22）Treatment-requiring accidental ingestion and risk factors among nursery children with food allergy
Yanagida N, Ebisawa M, Katsunuma T, Yoshizawa J
Pediatric Allergy and Immunology. 2021 Aug;32(6):1377-1380. Epub 2021 Apr 18.

23）Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA 2 LEN consensus
Hagemann J, Ebisawa M, et al
Allergy.2021 Aug.;76(8):2354-2366

24）Natural History of Allergy to Hen's Egg: A Prospective Study in Children Aged 6 to 12 Years
Taniguchi H, Ogura K, Sato S, Ebisawa M, Yanagida N.
International Archives of Allergy and Immunology. 2022 Jan.;183(1):14-24. Epub 2021 Sep 1.

25）Oral Wheat Immunotherapy: Long-Term Follow-Up in Children with Wheat Anaphylaxis
Babaie D, Ebisawa M, Soheili H, Ghasemi R, Zandieh F, Sahragard M, Seifi H, Fallahi M, Khoshmirsafa M, Darougar S, Mesdaghi M.
International Archives of Allergy and Immunology 2022 Feb.;183:306–314.Epub 2021 Nov 16.

26）WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation - Updates in COVID-19
Rouadi PW, Ebisawa M, de al
World Allergy Organization Journal.2021 Nov.;14(12):100618

27）WAO-ARIA consensus on chronic cough - Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
Rouadi PW, Ebisawa M, et al
World Allergy Organization Journal.2021 Dec.;14(12):100617

28）Food allergen ladders: A need for standardization
Venter C, Meyer R, Ebisawa M, Athanasopoulou P, Mack DP
Pediatr Allergy Immunol.2022 Jan.;33(1):e13714

29）World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - I - Plan and definitions
Fiocchi A, Bognanni A, Brożek J, Ebisawa M, Schünemann H; WAO DRACMA guideline group.
World Allergy Organ J.2022 Feb.;15(1):100609

30）Clinical cross-reactivity to quail's egg in patients with hen's egg allergy
Mitomori M, Yanagida N, Takei M, Tada K, Nishino M, Sato S, Ebisawa M
Pediatr Allergy Immunol.2022 Mar.;33(3):e13754

31）Anaphylaxis to winter melon due to cross-reactivity of sensitization to ragweed pollen
Nagakura KI, Takei M, Sato S, Yanagida N, Ebisawa M.
Pediatr Allergy Immunol.2022 Mar.;33(3):e13764

■Rheumatic Diseases

2023.4～2024.3

1）Accumulation of polyunsaturated fatty acid-derived metabolites in the sarcopenic muscle of aging mice
Kadoguchi T, Shimada K, Fukui N, Tanaka N, Tsuno H, Shiozawa T, Fukao K, Nishitani-Yokoyama M, Isoda K, Matsushita S, Yokoyama N, Daida H
Geriatrics and Gerontology International . 2023 Apr;23(4):297-303. Epub 2023 Feb 22.

2）Associations of HLA Polymorphisms with Chronic Kidney Disease in Japanese Rheumatoid Arthritis Patients
Higuchi T, Oka S, Furukawa H, Shimada K, Hashimoto A, Komiya A, Matsui T, Fukui N, Tohma S
Genes (Basel). 2023 Jul 19;14(7):1470.

3）Challenges faced by nurses engaged in rheumatology care in Japan
Fusama M, Nakahara H, Gregg M, Kuroe Y, Urata Y, Kawahata K, Kawahito Y, Kojima M, Sugihara T, Hashimoto M, Miyamae T, Murashima A, Mori M, Yajima N, Matsui T
Modern Rheumatology. 2023 Aug 4:road079.

4）Analysis of proteins released from osteoarthritic cartilage by compressive loading
Tsuno H, Tanaka N, Naito M, Ohashi S, Iwasawa M, Kadoguchi T, Mitomi H, Matsui T, Furukawa H, Fukui N
Scientific Reports. 2023 Oct 25;13(1):18292.

5）Association of a Single Nucleotide Variant in TERT with Airway Disease in Japanese Rheumatoid Arthritis Patients
Higuchi T, Oka S, Furukawa H, Shimada K, Tsunoda S, Ito S, Okamoto A, Fujimori M, Nakamura T, Katayama M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S
Genes (Basel). 2023 Nov 16;14(11):2084.

6）Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan
Mizushima M, Sugihara T, Matsui T, Urata Y, Tohma S, Kawahata K
Seminars in Arthritis and Rheumatism. 2023 Dec:63:152301. Epub 2023 Nov 3.

7）Factors associated with impaired physical function in elderly rheumatoid arthritis patients who had achieved low disease activity
Komiya Y, Sugihara T, Hirano F, Matsumoto T, Kamiya M, Sasaki H, Hosoya T, Kimura N, Ishizaki T, Mori M, Tohma S, Yasuda S, Matsui T.
Modern rheumatology. 2023 Dec 22;34(1):60-67

8）New Aspects of Clinical and Immunological Characteristics in Patients with Anti-asparaginyl tRNA synthetase (anti-KS) Autoantibody
Hosono Y, Ishi A, Izumi Y, Sasaki N, Nogi S, Yamada C, Sato S.
Modern Rheumatology. 2023 Dec 22;34(1):122-128

9）Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of DRB1*09:01
Nogi S, Oka S, Higuchi T, Furukawa H, Shimada K, Azuma T, Sugiyama T, Hirano F, Okamoto A, Fujimori M, Horai Y, Ihata A, Hashimoto A, Komiya A, Matsui T, Fukui N, Katayama M, Migita K, Tohma S
RMD Open. 2024 Jan 22;10(1):e003897.

10）Trends in Treatment for Patients with Late-onset Rheumatoid Arthritis in Japan: Data from the NinJa Study
Matsui T, Yoshida T, Nishino T, Yoshizawa S, Sawada T, Tohma S
Mod Rheumatol. 2024 Jan 22:roae006. Online ahead of print.

2022.4～2023.3

1）Lack of association of rs12702634 in RPA3-UMAD1 with interstitial lung diseases in Japanese rheumatoid arthritis patients.
Higuchi T, Oka S, Furukawa H, Shimada K, Tohma S.
Biomarker Insights. 2022 Apr 15;17:11772719221091758.

2）Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese.
Midorikawa R, Nakama M, Furukawa H, Oka S, Higuchi T, Nagai H, Nagai N, Tohma S.
Viruses. 2022 May 5;14(5):965.

3）Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease.
Oka S, Higuchi T, Furukawa H, Shimada K, Hashimoto A, Komiya A, Matsui T, Fukui N, Suematsu E, Ohno S, Kono H, Katayama M, Nagaoka S, Migita K, Tohma S
Scientific Reports.2022 Jun.;12(1):9916

4）Clinical variables, including novel joint index, associated with future patient-physician discordance in global assessment of rheumatoid arthritis (RA) disease activity based on a large RA database in Japan.
Yamamoto Y, Sawada T, Nishiyama S, Tahara K, Hayashi H, Mori H, Kato E, Tago M, Matsui T, Tohma S
International Journal of Rheumatic Diseases.2022 Sep.;25(9):1020-1028

5）Reversible improvement of arterial stenosis and wall thickness in Takayasu Arteritis through treatment with tocilizumab
Nogi S, Yano Y, Kodama K, Tsuno H, Ogihara H, Kawakami M, Ohmori T, Sato S, Matsui T.
Annals of Internal Medicine: Clinical Cases.2022 Nov.;

6）Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-center, randomized controlled trial.
Kimura N, Kawahara T, Uemura Y, Atsumi T, Sumida T, Mimura T, Kawaguchi Y, Amano H, Iwasaki Y, Kaneko Y, Matsui T, Muro Y, Imura Y, Kanda T, Tanaka Y, Kawakami A, Jinnin M, Ishii T, Hiromura K, Miwa Y, Nakajima H, Kuwana M, Nishioka Y, Morinobu A, Kameda H, Kohsaka H.
Rheumatology (Oxford). 2022 Nov.;61(11):4445-4454

7）Social independence evaluation index for Japanese patients with childhood-onset chronic diseases
Inoue Y, Umebayashi H, Matsui T, Nishiyama S, Sakurai I, Maru M, Takeda T, Tanigawa K1, Miyamae T.
Frontiers in Pediatrics.2022 Dec.; 10: 923497. eCollection 2022.

8）Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design
Kojima M, Kawahito Y, Sugihara T, Kojima T, Harada R, Hirata S, Hashimoto M, Hidaka T, Ishikawa H, Ito H, Kishimoto M, Kaneko Y, Matsui K, Matsui T, Matsushita I, Morinobu A, Nishida K, Tanaka E, Abe A, Ishitoku M, Asai S, Kida T, Onishi A, Takanashi S, Harigai M.
BMC Rheumatology.2022 Dec.; 6(1): 90

9) Association of a FAM13A variant with interstitial lung disease in Japanese rheumatoid arthritis.
Higuchi T, Oka S, Furukawa H, Shimada K, Tsunoda S, Ito S, Okamoto A, Katayama M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S
RMD Open. 2023 Jan;9(1):e002828.

10) Antibodies against serum anti-melanoma differentia-tion-associated gene 5 in rheumatoid arthritis patients with chronic lung diseases.
Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Hashimoto A, Komiya A, Saisho K, Yoshikawa N, Katayama M, Matsui T, Fukui N, Migita K, Tohma S
Medicina (Kaunas, Lithuania). 2023 Feb 14;59(2):363

11）Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study.
Nishino T, Hashimoto A, Tohma S, Matsui T.
BMC Rheumatology. 2023 Mar 21;7(1):4

2021.4～2022.3

1）Marked Effectiveness of Intravenous Immunoglobulin Therapy Against Intractable Lower Leg Ulcers in Two Patients With Rheumatoid Vasculitis.
Nogi S, Hashimoto A, Matsui T.
JCR: Journal of Clinical Rheumatology.2021 Apr.;27(5):e188-e189

2）Anti-Tumor Necrosis Factor α Therapy Induced Severe Lupus Nephritis in a Patient With Rheumatoid Arthritis.
Kakutani T, Nunokawa T, Hashimoto A, Matsui T.
J Clin Rheumatol.202 .Apr.;27(3):e104-e105

3）Cutaneous methotrexate-related T-cell lymphoproliferative disorder with CD4, CD30, CD56, EBV-positive tumor cell infiltration: a case illustration and a brief review
Omori I, Kawanabe R, Hashimoto Y, Mitsui A, Kodama K, Nogi S, Tsuno H, Horita A, Saito I, Ohmatsu H
American Journal Blood Research.2021 Apr.;11(2):163-167

4）Risk of serious infection, malignancy, or death in Japanese rheumatoid arthritis patients treated with a combination of abatacept and tacrolimus: a retrospective cohort study.
Tokunaga K, Matsui K, Oshikawa H, Matsui T, Tohma S
Clin Rheumatol.2021 May.;40(5):1811-1817

5）Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis
Furukawa H, Oka S, Higuchi T, Shimada K, Hashimoto A, Matsui T, Tohma S
Therapeutic Advances in Musculoskeletal Disease.2021 Jun.;13:1759720X211022506

6）Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Hashimoto A, Komiya A, Saisho K, Yoshikawa N, Katayama M, Matsui T, Fukui N, Migita K, Tohma S.
BMC Musculoskelet Disord.2022 Jan.;23(1):46

7）False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results.
Oka S, Higuchi T, Furukawa H, Shimada K, Hashimoto A, Matsui T, Tohma S.
SAGE Open Medicine. 2022 Mar.;10:20503121221088090. eCollection 2022.

8）Transitioning from paediatric to adult rheumatological healthcare: English summary of the Japanese Transition Support Guide.
Mori M, Akioka S, Igarashi T, Inoue Y, Umebayashi H, Ohshima S, Nishiyama S, Hashimoto M, Matsui T, Miyamae T, Yasumi T.
Mod Rheumatol.2022 Feb.;32(2):248-255

9）Distal Interphalangeal Joint Involvement May Be Associated with Disease Activity and Affected Joint Distribution in Rheumatoid Arthritis.
Mizuuchi T, Sawada T, Nishiyama S, Tahara K, Hayashi H, Mori H, Kato E, Tago M, Matsui T, Tohma S
Journal of Clinical Medicine.2022 Mar.;11(5):1405

■Rheumatic Diseases, Surgery Division

2023.4～2024.3

1）Predictors for hemostatic thrombin-gelatin matrix usage in spine surgery: a multicenter observational study
Kato S, Miyahara J, Matsubayashi Y, Taniguchi Y, Doi T, Kodama H, Higashikawa A, Takeshita Y, Fukushima M, Ono T, Hara N, Azuma S, Iwai H, Oshina M, Sugita S, Hirai S, Masuda K, Tanaka S, Oshima Y; University of Tokyo Spine Group
BMC Musculoskeletal Disorders . 2023 Apr 13;24(1):289.

2）Impact of body mass index on outcomes after lumbar spine surgery
Nakajima K, Miyahara J, Ohtomo N, Nagata K, Kato S, Doi T, Matsubayashi Y, Taniguchi Y, Kawamura N, Higashikawa A, Takeshita Y, Fukushima M, Ono T, Hara N, Azuma S, Iwai H, Oshina M, Sugita S, Hirai S, Masuda K, Tanaka S, Oshima Y
Scientific Reports . 2023 May 15;13(1):7862.

3）Frozen shoulder. An overview of pathology and biology with hopes to novel drug therapies
Tamai K, Hamada J, Nagase Y, Morishige M, Naito M, Asai H, Tanaka S
Modern Rheumatology . 2023 Aug 26;road087

4）Analysis of proteins released from osteoarthritic cartilage by compressive loading
Tsuno H，Tanaka N，Naito M，Ohashi S，Iwasawa M，Kadoguchi T，Mitomi H，Matsui T，Furukawa H，Fukui N
Scientific Reports. 2023 Oct 25;13(1):18292.

5）Comparative Analysis of Microendoscopic and Open Laminectomy for Single-Level Lumbar Spinal Stenosis at L1-L2 or L2-L3
Yamato Y, Nagata K, Kawamura N, Higashikawa A, Takeshita Y, Tozawa K, Fukushima M, Urayama D, Ono T, Hara N, Okamoto N, Azuma S, Iwai H, Sugita S, Yoshida Y, Hirai S, Masuda K, Jim Y, Ohtomo N, Nakamoto H, Kato S, Taniguchi Y, Tanaka S, Oshima Y
World Neurosurgery. 2024年3月:183:e408-e414　Epub 2023年 12 月23 日

2022.4～2023.3

1）Effect of TNF inhibitors with bisphosphonates vs bisphosphonates alone on bone mineral density and bone and cartilage biomarkers at 1 year in patients with rheumatoid arthritis: A prospective study
Nagase Y, Nagashima M, Shimane K, Nishikawa T, Naito M, Tanaka S.
Modern Rheumatology2022 Apr 18;32(3):517-521.

2）The contribution of deleterious rare alleles in ENPP1 and osteomalacia causative genes to atypical femoral fracture.
Furukawa H, Oka S, Kondo N, Nakagawa Y, Shiota N, Kumagai K, Ando K, Takeshita T, Oda T, Takahashi Y, Izawa K, Iwasaki Y, Hasegawa K, Arino H, Minamizaki T, Yoshikawa N, Takata S, Yoshihara Y, Tohma S.
The Journal of Clinical Endocrinology & Metabolism.2022 Apr 19;107(5):e1890-e1898.

3）Lumbar Fusion including Sacroiliac Joint Fixation Increases the Stress and Angular Motion at the Hip Joint: A Finite Element Study
Kozaki T, Hashizume H, Oka H, Ohashi S, Kumano Y, Yamamoto E, Minamide A, Yukawa Y, Iwasaki H, Tsutsui S, Takami M, Nakata K, Taniguchi T, Fukui D, Nishiyama D, Yamanaka M, Tamai H, Taiji R, Murata S, Murata A, Yamada H.
Spine Surgery and Related Research.2022 Apr.; 6(6): 681-688

4）Postoperative outcomes after degenerative lumbar spine surgery in rheumatoid arthritis patients -a propensity score-matched analysis
Kato S, Nakamoto H, Matsubayashi Y, Taniguchi Y, Doi T, Yoshida Y, Higashikawa A, Takeshita Y, Fukushima M, Ono T, Hara N, Okazaki R, Iwai H, Oshina M, Sugita S, Hirai S, Masuda K, Tanaka S, Oshima Y; University of Tokyo Spine Group
BMC Musculoskeletal Disorders 2022 Apr.;23(1):380

5）Characteristics of gene expression in frozen shoulder
Nishimoto H, Fukuta S, Fukui N, Sairyo K, Yamaguchi T
BMC Musculoskeletal Disorders 2022 Aug.;23(1):811

6）Evaluation of bone strength using finite-element analysis in patients with ossification of the posterior longitudinal ligament
Doi T, Ohashi S, Ohtomo N, Tozawa K, Nakarai H, Yoshida Y, Ito Y, Sakamoto R, Nakajima K, Nagata K, Okamoto N, Nakamoto H, Kato S, Taniguchi Y, Matsubayashi Y, Tanaka S, Oshima Y.
The Spine Journal.2022 Aug;22(8):1399-1407.Epub 2022 Mar 5.

7）Accumulation of polyunsaturated fatty acid-derived metabolites in the sarcopenic muscle of aging mice
Kadoguchi T, Shimada K, Fukui N, Tanaka N, Tsuno H, Shiozawa T, Fukao K, Nishitani-Yokoyama M, Isoda K, Matsushita S, Yokoyama N, Daida H.
Geriatrics and Gerontology International.2023 Fev.:

8）Erratum for Lumbar Fusion including Sacroiliac Joint Fixation Increases the Stress and Angular Motion at the Hip Joint: A Finite Element Study
Kozaki T, Hashizume H, Oka H, Ohashi S, Kumano Y, Yamamoto E, Minamide A, Yukawa Y, Iwasaki H, Tsutsui S, Takami M, Nakata K, Taniguchi T, Fukui D, Nishiyama D, Yamanaka M, Tamai H, Taiji R, Murata S, Murata A, Yamada H.
Spine Surgery and Related Research. 2023 Mar 27;7(2):199.

2021.4～2022.3

1）Fracture of ossified Achilles tendons: A review of cases
Ishikura H, Fukui N, Iwasawa M, Ohashi S, Tanaka T, Tanaka S.
World Journal of Orthopedics.2021 Apr.;12(4):207-213

2）Cutaneous methotrexate-related T-cell lymphoproliferative disorder with CD4, CD30, CD56, EBV-positive tumor cell infiltration: a case illustration and a brief review
Omori I, Kawanabe R, Hashimoto Y, Mitsui A, Kodama K, Nogi S, Tsuno H, Horita A, Saito I, Ohmatsu H
American Journal Blood Research.2021 Apr.;11(2):163-167

3）Systemic inflammatory responses after orthopedic surgery in patients with rheumatoid arthritis treated with tofacitinib
Uchio A, Matsumoto T, Maenohara Y, Omata Y, Takahashi H, Iwasawa M, Juji T, Nakamura I, Tanaka S.
Clinical Rheumatology.2021 Dec.;40(12):5077-5083

4）Correction to: Systemic inflammatory responses after orthopedic surgery in patients with rheumatoid arthritis treated with tofacitinib
Uchio A, Matsumoto T, Maenohara Y, Omata Y, Takahashi H, Iwasawa M, Juji T, Nakamura I, Tanaka S.
Clinical Rheumatology.2021 Dec.;40(12):5085

5）Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Hashimoto A, Komiya A, Saisho K, Yoshikawa N, Katayama M, Matsui T, Fukui N, Migita K, Tohma S.
BMC Musculoskelet Disord.2022 Jan.;23(1):46

■Clinical Immunology

2023.4～2024.3

1）Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases
Nakamura Y, Moi ML, Shiina T, Shin-I T, Suzuki R
Viruses . 2023 May 17;15(5):1186.

2）Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam
Nguyen TTN, Choo EM, Nakamura Y, Suzuki R, Shiina T, Shin-I T, Fukuta M, Nguyen CT, Nguyen TTT, Nguyen LKH, Hoang VMP, Morita K, Dang DA, Hasebe F, Le TQM, Moi ML
International Journal of Infectious Diseases. 2024 Feb:139:109-117. Epub 2023 Nov 19.

2022.4～2023.3

1）Characterization of Metal-Specific T-Cells in Inflamed Oral Mucosa in a Novel Murine Model of Chromium-Induced Allergic Contact Dermatitis
Yoshizawa T, Kumagai K, Matsubara R, Nasu K, Kitaura K, Suzuki M, Hamada Y, Suzuki R
International Journal of Molecular Sciences.2023 Fev.; 24(3): 2807

2）Type IVb Hypersensitivity Reaction in the Novel Murine Model of Palladium-Induced Intraoral Allergic Contact Mucositis
Nasu K, Kumagai K, Yoshizawa T, Kitaura K, Matsubara R, Suzuki M, Suzuki R, Hamada Y
International Journal of Molecular Sciences.2023 Feb.; 24(4): 3137

3）Cross-Reactivity of Intraoral Allergic Contact Mucositis in the Nickel-Sensitized Ear Model of Metal Allergy
Matsubara R, Kumagai K, Nasu K, Yoshizawa T, Kitaura K, Suzuki M, Hamada Y, Suzuki R
International Journal of Molecular Sciences.2023 Feb.; 24(4): 3965

2021.4～2022.3
1）Pharmacological MEK inhibition promotes polyclonal T-cell reconstitution and suppresses xenogeneic GVHD
Itamura H, Shindo T, Muranushi H, Kitaura K, Okada S, Shin-I T, Suzuki R, Takaori-Kondo A, Kimura S.
Cellular Immunology.2021 Sep.;367:104410

■Intractable Neurological Diseases

2023.4～2023.4

1）Treatment Methods for Dystonia, Myoclonus, and Chorea
Hasegawa K
Brain and Nerve. 2023 May;75(5):542-548.

2）Genome-wide association study identifies a new susceptibility locus in PLA2G4C for Multiple System Atrophy
Nakahara Y, Hasegawa K
medRxiv . 2023 May 2

3）Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients
Nakamura R, Tohnai G, Nakatochi M, Atsuta N, Watanabe H, Ito D, Katsuno M, Hirakawa A, Izumi Y, Morita M, Hirayama T, Kano O, Kanai K, Hattori N, Taniguchi A, Suzuki N, Aoki M, Iwata I, Yabe I, Shibuya K, Kuwabara S, Oda M, Hashimoto R, Aiba I, Ishihara T, Onodera O, Yamashita T, Abe K, Mizoguchi K, Shimizu T, Ikeda Y, Yokota T, Hasegawa K, Tanaka F, Nakashima K, Kaji R, Niwa JI, Doyu M, Terao C, Ikegawa S, Fujimori K, Nakamura S, Ozawa F, Morimoto S, Onodera K, Ito T, Okada Y, Okano H, Sobue G; Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS) study group
Journal of Neurology, Neurosurgery and Psychiatry . 2023　Oct;94(10):816-824. Epub 2023 May 4.

4）Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome
Aiba I, Hayashi Y, Shimohata T, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Tokumaru AM, Sakurai K, Murayama S, Hasegawa K, Uchihara T, Toyoshima Y, Saito Y, Yabe I, Tanikawa S, Sugaya K, Hayashi K, Sano T, Takao M, Sakai M, Fujimura H, Takigawa H, Adachi T, Hanajima R, Yokota O, Miki T, Iwasaki Y, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Tanaka M, Idezuka J, Kanazawa M, Aoki K, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Mukai E, Kubota A, Toda T, Nakashima K; J-VAC study group.
Brain Communications. 2023 Nov 3;5(6):fcad296.

5）Randomized controlled trial of KW-6356 monotherapy in patients with early untreated Parkinson's disease
Maeda T, Kimura T, Sugiyama K, Yamada K, Hiraiwa R, Nishi M, Hattori N; 6356-002 study group.
Parkinsonism and Related Disorders. 2023 Dec:117:105907.

6) An autopsy case of variably protease-sensitive prionopathy with Met/Met homogeneity at codon 129
Uchino A, Saito Y, Oonuma S, Murayama S, Yagishita S, Kitamoto T, Hasegawa K
Neuropathology . 2023 Dec;43(6):486-495.　 Epub 2023 May 30.

7）An autopsy case of MV 2K + C subtype of Creutzfeldt-Jakob disease
Uchino A, Saito Y, Tokuda S, Saburo Y, Murayama S, Hasegawa K.
Neuropathology. 2024 Feb 14.

2022.4～2023.3

1）Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis
Tohnai G, Nakamura R, Atsuta N, Nakatochi M, Hayashi N, Ito D, Watanabe H, Watanabe H, Katsuno M, Izumi Y, Taniguchi A, Kanai K, Morita M, Kano O, Kuwabara S, Oda M, Abe K, Aoki M, Aiba I, Okamoto K, Mizoguchi K, Ishihara T, Kawata A, Yokota T, Hasegawa K, Nagano I, Yabe I, Tanaka F, Kuru S, Hattori N, Nakashima K, Kaji R, Sobue G; Japanese Consortium for Amyotrophic Lateral Sclerosis Research (JaCALS).
Neurobiology of Aging 2022 May.;113:131-136

2）Age-dependent formation of TMEM106B amyloid filaments in human brains
Schweighauser M, Arseni D, Bacioglu M, Huang M, Lövestam S, Shi Y, Yang Y, Zhang W, Kotecha A, Garringer HJ, Vidal R, Hallinan GI, Newell KL, Tarutani A, Murayama S, Miyazaki M, Saito Y, Yoshida M, Hasegawa K, Lashley T, Revesz T, Kovacs GG, van Swieten J, Takao M, Hasegawa M, Ghetti B, Spillantini MG, Ryskeldi-Falcon B, Murzin AG, Goedert M, Scheres SHW.
Nature 2022 May.;605(7909):310-314

3）Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Tarutani A, Adachi T, Akatsu H, Hashizume Y, Hasegawa K, Saito Y, Robinson AC, Mann DMA, Yoshida M, Murayama S, Hasegawa M.
Acta Neuropathologica 2022 May.;1438(6):613-640

4）Structures of α-synuclein filaments from human brains with Lewy pathology
Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG, Garringer HJ, Cullinane PW, Saito Y, Foroud T, Warner TT, Hasegawa K, Vidal R, Murayama S, Revesz T, Ghetti B, Hasegawa M, Lashley T, Scheres SHW, Goedert M.
Nature.2022 Oct.; 610(7933): 791-795

5）Neuropathology of spinocerebellar ataxia type 8: Common features and unique tauopathy
Yonenobu Y, Beck G, Kido K, Maeda N, Yamashita R, Inoue K, Saito Y, Hasegawa M, Ito H, Hasegawa K, Morii E, Iwaki T, Murayama S, Mochizuki H.
Neuropathology.2023 Jan.;

2021.4～2022.3

1）Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy
Lövestam S,Schweighauser M,Matsubara T,Murayama S,Tomita T,Ando T,Hasegawa K,Yoshida M,Tarutani A,Hasegawa M,Goedert M,H W Scheres S
FEBS Open Bio.2021 Apr.;11(4):999-1013

2）Cognitive and behavioral status in Japanese ALS patients: a multicenter study
Watanabe Y, Raaphorst J, Izumi Y, Yoshino H, Ito S, Adachi T, Takigawa H, Masuda M, Atsuta N, Adachi Y, Isose S, Arai K, Yokota O, Oda M, Ogino M, Ichikawa H, Hasegawa K, Kimura H, Shimizu T, Aiba I, Yabe H, Kanba M, Kusumi K, Aoki T, Hiroe Y, Watanabe H, Nishiyama K, Nomoto M, Sobue G, Beeldman E, Hanajima R, Nakashima K
Journal of Neurology.2021 May,;267(5):1321-1330

3）Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-Label Extension of a Phase three Randomized Controlled Trial
Odawara T, Hasegawa K, Kajiwara R, Takeuchi H, Tagawa M, Kosaka K, Murata M.
The American Journal of Geriatric Psychiatry.2021 Jul.;10:S1064-7481(21)00385-7

4）Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
Tarutani A, Miyata H, Nonaka T, Hasegawa K, Yoshida M, Saito Y, Murayama S, Robinson AC, Mann DMA, Tomita T, Hasegawa M.
Brain.2021 Sep;144(8):2333-2348

5）Efficacy and Safety of Zonisamide in Dementia with Lewy Bodies Patients with Parkinsonism: A Post Hoc Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials
Hasegawa K, Kochi K, Maruyama H, Konishi O, Toya S, Odawara T
Journal of Alzheimer's Disease.2021 Dec.;79(2):627-637

6）Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis
Tohnai G,Hasegawa K, et al
Neurobiol Aging.2021 Dec.; Online ahead of print.

7）Efficacy of Wearable Device Gait Training on Parkinson's Disease: A Randomized Controlled Open-label Pilot Study
Kawashima N, Hasegawa K, Iijima M, Nagami K, Makimura T, Kumon A, Ohtsuki S.
Intern Med. 2022 Sep 1;61(17):2573-2580. Epub 2022 Feb 8.

8）Age-dependent formation of TMEM106B amyloid filaments in human brains
Schweighauser M,Hasegawa K, et al
Nature. 2022 May;605(7909):310-314.Epub 2022 Mar 28.

■Nasal Allergy

■Skin Allergy

2023.4～2024.3

1）Rapidly Progressive Multiple Skin Plaques and Nodules: A Quiz
Boki H, Miyagaki T, Suga H, Ohmatsu H, Sato S
Acta Dermato-Venereologica . 2023 Jun 22

2021.4～2022.3

1) Cutaneous methotrexate-related T-cell lymphoproliferative disorder with CD4, CD30, CD56, EBV-positive tumor cell infiltration: a case illustration and a brief review
Omori I, Kawanabe R, Hashimoto Y, Mitsui A, Kodama K, Nogi S, Tsuno H, Horita A, Saito I, Ohmatsu H.
American Journal of Blood Research. 2021 Apr.；11(2)：163-167

■Tumor Immunology

2021.4～2022.3

1）A single-nucleotide-polymorphism in the 5'-flanking region of MSX1 gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma
Mori T, Ueno K, Tokunaga K, Kawai Y, Matsuda K, Nishida N, Komine K, Saito S, Nagasaki M; BioBank Japan Project.
Therapeutic Advances in Medical Oncology.2022 Feb.;14:17588359221080580

■Surgical Immunology

2023.4～2024.3

1）A Japanese Prospective, Multicenter Study of Colonic Stenting for Palliation Using a High Axial Force Self-Expandable Metal Stent for Malignant Large Bowel Obstruction in 200 Patients
Ishibashi R, Sasaki T, Isayama H, Matsuzawa T, Kuwai T, Yamada T, Saito S, Tomita M, Shiratori T, Ikeda S, Kanazawa H, Fujishiro M, Maetani I, Saida Y.
Journal of Clinical Medicine.2023 Aug 5;12(15):5134.